Atlas Trials

NaviFUS Corporation

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch NaviFUS Corporation

RecordFirmDate
A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients (NCT06496971)NaviFUS Corporation2024-11-08
Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM) (NCT06329570)NaviFUS Corporation2024-10-22
A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy (NCT06388707)NaviFUS Corporation2024-09-13
A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy (NCT06492720)NaviFUS Corporation2024-09-01
NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy (NCT04999046)NaviFUS Corporation2021-10-07
Evaluate the Safety and Preliminary Efficacy of the Combination of NaviFUS System With Re-irradiation for rGBM Patients (NCT04988750)NaviFUS Corporation2021-05-23
Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients (NCT04446416)NaviFUS Corporation2020-07-21
Safety of Using NaviFUS System in Patients With Drug Resistant Epilepsy (NCT03860298)NaviFUS Corporation2019-06-17
Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients (NCT03626896)NaviFUS Corporation2018-08-17

Track NaviFUS Corporation automatically

Every clearance here is in the API, with alerts when new ones post.